Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

859
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
859
Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

986
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
986
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

7.2K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
7.2K
Blood Flow01:29

Blood Flow

75.1K
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
75.1K
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

1.7K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Slow unsteady gait in a population-based cohort: links to ventriculomegaly and INPH-related imaging markers.

Fluids and barriers of the CNS·2026
Same author

Can AI applied on MRI reliably predict shunt response in INPH? A comprehensive exploration of deep learning and radiomics approaches using preoperative MRI.

PloS one·2026
Same author

Increasing statistical power in functional MRI through permutation and multivariate statistics.

Cognitive neuroscience·2026
Same author

Quantifying Cardiac, Respiratory, and Low Frequency Components of CSF Motion From fMRI Inflow Effects.

Magnetic resonance in medicine·2026
Same author

Telemetric lumbar cerebrospinal fluid pressure monitoring for spaceflight: a novel approach to spaceflight-associated neuro-ocular syndrome research.

NPJ microgravity·2026
Same author

Quantitative assessment of flow between cerebrospinal and interstitial fluid compartments in humans.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Dec 5, 2025

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
07:18

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography

Published on: February 18, 2022

2.0K

Intraocular Pressure Decrease Does Not Affect Blood Flow Rate of Ophthalmic Artery in Ocular Hypertension.

Gauti Jóhannesson1,2, Sara Qvarlander3,4, Anders Wåhlin3,4,5

  • 1Department of Clinical Sciences, Ophthalmology, Umeå University, Umeå, Sweden.

Investigative Ophthalmology & Visual Science
|October 19, 2020
PubMed
Summary
This summary is machine-generated.

Lowering intraocular pressure (IOP) with latanoprost did not alter ophthalmic artery blood flow in ocular hypertension patients. This suggests a protective mechanism maintaining eye blood supply despite IOP changes.

More Related Videos

Doppler Optical Coherence Tomography of Retinal Circulation
10:46

Doppler Optical Coherence Tomography of Retinal Circulation

Published on: September 18, 2012

19.1K
Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

10.3K

Related Experiment Videos

Last Updated: Dec 5, 2025

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
07:18

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography

Published on: February 18, 2022

2.0K
Doppler Optical Coherence Tomography of Retinal Circulation
10:46

Doppler Optical Coherence Tomography of Retinal Circulation

Published on: September 18, 2012

19.1K
Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

10.3K

Area of Science:

  • Ophthalmology
  • Cardiovascular Research
  • Medical Imaging

Background:

  • Ocular hypertension is a risk factor for glaucoma.
  • Understanding the relationship between intraocular pressure (IOP) and ocular blood flow is crucial for managing eye diseases.
  • The ophthalmic artery (OA) is the primary blood supplier to the eye.

Purpose of the Study:

  • To determine if reducing IOP affects volumetric blood flow rate in the ophthalmic artery (OA) of patients with untreated ocular hypertension.
  • To investigate the impact of latanoprost treatment on OA blood flow.

Main Methods:

  • 30 subjects with untreated ocular hypertension underwent 3-Tesla MRI with 3D phase-contrast imaging to measure OA blood flow.
  • Latanoprost was administered to the higher-pressure eye, with the contralateral eye serving as a control.
  • Measurements were repeated after approximately one week.

Main Results:

  • Latanoprost significantly reduced IOP by 7.2 ± 3.1 mm Hg in the treated eye (P < 0.01).
  • No significant difference in OA blood flow rate was observed before and after treatment in either the treated (12.4 ± 4.4 vs. 12.4 ± 4.6 mL/min, P = 0.92) or control eye (13.5 ± 5.2 vs. 13.4 ± 4.1 mL/min, P = 0.92).
  • There was no significant difference in the change of blood flow rate between the treated and control eyes (0.1 ± 3.1 vs. -0.1 ± 4.0 mL/min, P = 0.84).

Conclusions:

  • A significant reduction in IOP does not impact OA blood flow rate in patients with ocular hypertension.
  • The eye may possess a mechanism to maintain blood supply independently of IOP fluctuations.
  • This independence could be a protective factor in preserving vision for individuals with ocular hypertension.